Form 4: United Therapeutics Director Richard Giltner Executes Share Tracking Award, Disposes of Shares
SEC Form 4 Filing
Director Richard Giltner executed a share tracking award and disposed of 10,000 shares of United Therapeutics Corp stock on March 6, 2024.
Summary
- On March 6, 2024, Richard Giltner, a director of United Therapeutics Corp, executed a share tracking award.
- Giltner disposed of 10,000 shares of common stock at a price of $236.97.
- He also acquired 10,000 shares of common stock at a price of $88.03.
- Following these transactions, Giltner beneficially owns 15,620 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. The director disposed of shares, but also acquired shares through a share tracking award execution. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. It allows investors to monitor the actions of key personnel and their potential impact on the stock's performance.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company directors as an indicator of management's confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 06/26/2015 | Date Share Tracking Award became exercisable |
| 03/06/2024 | Date of transaction: execution of share tracking award and stock disposal/acquisition |
| 06/26/2024 | Expiration date of Share Tracking Award |
| 03/07/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.